Once monthly injectables to become future therapeutic options for obesity: Report New Delhi, Jan 12: From once-weekly subcutaneously injectable medicines agonizing the glucagon-like peptide 1 receptor (GLP-1R), longer-acting candidates allowing once-monthly administration may becom...
